54.58
price down icon2.90%   -1.63
after-market Handel nachbörslich: 54.55 -0.03 -0.05%
loading

Finanzdaten der Vaxcyte Inc-Aktie (PCVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
7.14%
242.38
226.22 180.79 162.17 139.92
Operating Income/Loss
7.14%
-242.38
-226.22 -180.79 -162.17 -139.92
Nonoperating Income/Loss
50.46%
29.55
59.65 40.08 - -
Income/Loss From Continuing Operations Before Tax
27.77%
-212.83
-166.57 -140.72 -137.08 -103.12
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
27.77%
-212.83
-166.57 -140.72 -137.08 -103.12
Net Income/Loss
27.77%
-212.83
-166.57 -140.72 -137.08 -103.12
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.12%
136.20
136.03 135.69 4.4009 123.69
Diluted Average Shares
0.12%
136.20
136.03 135.69 4.4009 123.69
Basic Earnings Per Share
27.87%
-1.56
-1.22 -1.04 -1.02 -0.83
Diluted Earnings Per Share
27.87%
-1.56
-1.22 -1.04 -1.02 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):